Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Chinese Patent Office
Cantor Fitzgerald
Medtronic
AstraZeneca
Baxter
QuintilesIMS
US Army
Express Scripts
UBS

Generated: October 23, 2017

DrugPatentWatch Database Preview

Roche Palo Company Profile

« Back to Dashboard

What is the competitive landscape for ROCHE PALO, and what generic and branded alternatives to ROCHE PALO drugs are available?

ROCHE PALO has fourteen approved drugs.



Summary for Applicant: Roche Palo

US Patents:0
Tradenames:7
Ingredients:9
NDAs:14
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche Palo
CELLCEPT
mycophenolate mofetil hydrochloride
INJECTABLE;INJECTION050758-001Aug 12, 1998APRXYesYes► Subscribe► Subscribe► Subscribe
Roche Palo
CELLCEPT
mycophenolate mofetil
CAPSULE;ORAL050722-001May 3, 1995ABRXYesYes► Subscribe► Subscribe► Subscribe
Roche Palo
CYTOVENE
ganciclovir
CAPSULE;ORAL020460-002Dec 12, 1997DISCNYesNo► Subscribe► Subscribe► Subscribe
Roche Palo
FEMSTAT
butoconazole nitrate
SUPPOSITORY;VAGINAL019359-001Nov 25, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Roche Palo
TICLID
ticlopidine hydrochloride
TABLET;ORAL019979-002Oct 31, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Roche Palo
TORADOL
ketorolac tromethamine
INJECTABLE;INJECTION019698-002Nov 30, 1989DISCNYesNo► Subscribe► Subscribe► Subscribe
Roche Palo
AEROBID
flunisolide
AEROSOL, METERED;INHALATION018340-001Aug 17, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Roche Palo
EVEX
estrogens, esterified
TABLET;ORAL083376-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Roche Palo
CELLCEPT
mycophenolate mofetil
TABLET;ORAL050723-001Jun 19, 1997ABRXYesYes► Subscribe► Subscribe► Subscribe
Roche Palo
TICLID
ticlopidine hydrochloride
TABLET;ORAL019979-001Mar 24, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Roche Palo

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche Palo
CYTOVENE
ganciclovir sodium
INJECTABLE;INJECTION019661-001Jun 23, 1989► Subscribe► Subscribe
Roche Palo
CYTOVENE
ganciclovir
CAPSULE;ORAL020460-002Dec 12, 1997► Subscribe► Subscribe
Roche Palo
FEMSTAT
butoconazole nitrate
CREAM;VAGINAL019215-001Nov 25, 1985► Subscribe► Subscribe
Roche Palo
CELLCEPT
mycophenolate mofetil
SUSPENSION;ORAL050759-001Oct 1, 1998► Subscribe► Subscribe
Roche Palo
TICLID
ticlopidine hydrochloride
TABLET;ORAL019979-002Oct 31, 1991► Subscribe► Subscribe
Roche Palo
CYTOVENE
ganciclovir
CAPSULE;ORAL020460-002Dec 12, 1997► Subscribe► Subscribe
Roche Palo
CYTOVENE
ganciclovir
CAPSULE;ORAL020460-001Dec 22, 1994► Subscribe► Subscribe
Roche Palo
CYTOVENE
ganciclovir
CAPSULE;ORAL020460-002Dec 12, 1997► Subscribe► Subscribe
Roche Palo
CYTOVENE
ganciclovir sodium
INJECTABLE;INJECTION019661-001Jun 23, 1989► Subscribe► Subscribe
Roche Palo
CELLCEPT
mycophenolate mofetil hydrochloride
INJECTABLE;INJECTION050758-001Aug 12, 1998► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for ROCHE PALO drugs

Drugname Dosage Strength Tradename Submissiondate
mycophenolic mofetil
For Oral Suspension200 mg/mL
CELLCEPT
3/25/2011

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Covington
QuintilesIMS
Accenture
Citi
Healthtrust
Julphar
Express Scripts
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot